Chronic viral hepatitis
- 30 April 2003
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 17 (2), 259-275
- https://doi.org/10.1016/s1521-6918(03)00014-3
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- GS-98-438 a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B: 48 week resultsJournal of Hepatology, 2002
- Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV doseJournal of Hepatology, 2002
- Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factorsJournal of Hepatology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Hepatocellular carcinomaJournal of Hepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in FranceJournal of Hepatology, 1994
- Long-term evolution of chronic delta hepatitis in childrenThe Journal of Pediatrics, 1993
- Familiar clustering and spreading of hepatitis delta virus infectionJournal of Hepatology, 1985